0001140361-20-006260.txt : 20200318 0001140361-20-006260.hdr.sgml : 20200318 20200318213212 ACCESSION NUMBER: 0001140361-20-006260 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200316 FILED AS OF DATE: 20200318 DATE AS OF CHANGE: 20200318 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Davis Katherine Lyon CENTRAL INDEX KEY: 0001399265 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35569 FILM NUMBER: 20726269 MAIL ADDRESS: STREET 1: C/O CHEMBIO DIAGNOSTICS STREET 2: 3661 HORSEBLOCK ROAD CITY: MEDFORD STATE: NY ZIP: 11763 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CHEMBIO DIAGNOSTICS, INC. CENTRAL INDEX KEY: 0001092662 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 880425691 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 555 WIRELESS BLVD. CITY: HAUPPAUGE STATE: NY ZIP: 11788 BUSINESS PHONE: (631) 924-1135 MAIL ADDRESS: STREET 1: 555 WIRELESS BLVD. CITY: HAUPPAUGE STATE: NY ZIP: 11788 FORMER COMPANY: FORMER CONFORMED NAME: Chembio Diagnostics Inc. DATE OF NAME CHANGE: 20040607 FORMER COMPANY: FORMER CONFORMED NAME: TRADING SOLUTIONS COM INC DATE OF NAME CHANGE: 19990805 4 1 form4.xml FORM 4 X0306 4 2020-03-16 0001092662 CHEMBIO DIAGNOSTICS, INC. CEMI 0001399265 Davis Katherine Lyon 555 WIRELESS BOULEVARD HAUPPAUGE NY 11788 true Restricted Stock Units 2020-03-16 4 A 0 16314 0 A Common Stock 16314 16314 D Option to purchase 2.36 2020-03-16 4 A 0 36252 0 A 2027-03-15 Common Stock 36252 36252 D Each restricted stock unit represents a contingent right to receive one share of Common Stock. The restricted stock units are scheduled to vest in full immediately prior to the earlier to occur of (i) the 2021 annual meeting of stockholders of the issuer, and (ii) a Change in Control (as defined in the 2019 Omnibus Incentive Plan of the issuer). The option is scheduled to vest and become exercisable in full immediately prior to the earlier to occur of (i) the 2021 annual meeting of stockholders of the issuer, and (ii) a Change in Control. /s/ Mark L. Johnson, Attorney-in-Fact for Katherine Lyon Davis 2020-03-18